Pad for a mask

Information

  • Patent Grant
  • 11013878
  • Patent Number
    11,013,878
  • Date Filed
    Tuesday, January 16, 2018
    6 years ago
  • Date Issued
    Tuesday, May 25, 2021
    3 years ago
Abstract
A cushion pad for a mask worn by a patient, comprising a first side to contact skin of the patient, and a second side, opposite the first side, to contact or face the mask. The pad has a main body portion having a central portion shaped to cover a portion of the patient's nose extending from above the nose tip to the nasal bridge region without obstructing the patient's line of sight, and lateral side portions to extend downward and terminate along the sides of the nose or on the patient's cheeks. The main body is made of a breathable material, e.g., foam. The pad may include adhesive and/or an attached portion, e.g., a ring, to couple the pad to the patient and/or portion of the mask.
Description
FIELD OF THE INVENTION

The present invention relates to a pad for a respiratory mask for the delivery of respiratory therapy to a patient. Various respiratory conditions include Sleep Disordered Breathing (SDB) and particularly Obstructive Sleep Apnea (OSA). Respiratory therapies used to treat these conditions include Continuous Positive Airway Pressure (CPAP), Non-Invasive Positive Pressure Ventilation (NIPPV), and Variable Positive Airway Pressure (VPAP).


BACKGROUND OF THE INVENTION

Typically, respiratory therapy is delivered in the form of a respiratory mask or mask system positioned between a patient and apparatus providing a supply of pressurized air or breathing gas. Mask systems in the field of the invention differ from mask systems used in other applications such as aviation and safety in particular because of their emphasis on comfort. This high level of comfort is desired because patients must sleep wearing the masks for hours, possibly every night for the rest of their lives. In addition, therapy compliance can be improved if the patient's bed partner is not adversely affected by the patient's therapy and wearing of the mask generally.


Mask systems typically, although not always, comprise (i) a rigid or semi-rigid portion often referred to as a shell or frame, (ii) a soft, patient contacting portion often referred to as a cushion, and (iii) some form of headgear to hold the frame and cushion in position. If the mask system does include multiple components, at least some assembly and adjustment may be required, which can be difficult for patients who may suffer from lack of dexterity, etc. Further, mask systems often include a mechanism for connecting an air delivery conduit. The air delivery conduit may preferably be connected to a blower or flow generator.


A range of mask systems are known including nasal masks, nose & mouth masks, full face masks and nasal prongs, pillows, nozzles & cannulae. Masks typically cover more of the face than nasal prongs, pillows, nozzles and cannulae.


Some respiratory masks cause discomfort or are difficult to seal on some patients. Comfort and seal may be particularly troublesome in the nasal bridge region. Other portions of the mask system including but not limited to the forehead support and headgear clips may cause discomfort or cause skin breakdown (e.g. ulceration, skin marking, irritation, redness, etc).


SUMMARY OF THE INVENTION

One aspect of the present technology relates to a pad for a mask system.


One form of a pad in accordance with the present technology comprises a pad for a mask system with an adhesive. In another form, no adhesive is used.


In accordance with one aspect of the present technology, a mask system including a cushion is provided. A pad may be removably held in fixed spacial relation with respect to the cushion. In one form the pad may be tethered to the mask system. In one form the pad may be secured at a particular location on the mask so that it does not fall off when the mask is removed from the face. In one form the pad comprises a tether so that the pad may be selectively held at different regions of the cushion to resolve a seal problem at the different regions. In one form the mask system further includes a mechanical fastener to hold a pad. In one form a pad may be tethered to the mask system without requiring the pad to be held in a fixed location with respect to the cushion. In one form in accordance with the present technology, a pad further comprising a tether is provided.


One form of pad in accordance with the present technology relates to a pad for use with a forehead support. In one form a pad comprises a portion for use with a forehead support and a portion for use with a nasal cushion.


Another aspect of the present invention relates to a pad for a mask system with an attachment portion, e.g., the pad is shaped to cover a designated portion of the patient's face, e.g., the forehead, the nasal bridge region, the cheek region and/or the upper lip or lower lip/chin region, and the attachment portion may be releasably connected to the mask system, e.g., a forehead support (dial, joining member, etc.), frame, headgear, and/or headgear clip, etc.


Another aspect of the present invention relates to a cushion pad for a mask worn by a patient, comprising a first side to contact skin of the patient, a second side, opposite the first side, to contact the mask, the pad having a main body portion having a central portion shaped to cover the nasal bridge region of the patient, the main body portion having an attachment portion to attach the cushion pad to the mask.


Another aspect of the present invention relates to a cushion pad for a mask worn by a patient, comprising a first side to contact skin of the patient, and a second side, opposite the first side, to contact or face the mask, the pad having a main body portion having a central portion shaped to cover a portion of the patient's nose extending from above the nose tip to the nasal bridge region without obstructing the patient's line of sight, and lateral side portions to extend downward and terminate along the sides of the nose or on the patient's cheeks, the main body being made of a breathable material.


Another aspect of the present invention relates to a cushion pad for a mask worn by a patient, comprising a first side to contact skin of the patient, and a second side, opposite the first side, to contact or face the mask, the pad having a main body portion having a central portion shaped to cover a portion of the patient's nose extending from above the nose tip to the nasal bridge region without obstructing the patient's line of sight, and lateral side portions to extend downward along the sides of the nose, the main body being made of a conformable material.


Another aspect of the invention relates to methods of manufacturing a mask pad, e.g., via thermoforming, molding, machining, stitching, die cutting and/or compression cutting.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of various embodiments of the present technology.



FIG. 1 shows a perspective view of a first embodiment of the present invention.



FIG. 2 shows a plan view of a first embodiment of the present invention.



FIG. 3 shows a perspective view of a first embodiment of the present invention in use.



FIG. 4 shows a perspective view of a first embodiment of the present invention in use.



FIG. 5 shows a perspective view of a first embodiment of the present invention in use.



FIGS. 5A to 5G show alternatives of the first embodiment.



FIG. 6 shows a plan view of a second embodiment of the present invention.



FIG. 7 shows a front view of a second embodiment of the present invention with a mask system.



FIG. 8 shows a back view of a second embodiment of the present invention in use.



FIG. 9 shows a side view of a second embodiment of the present invention in use.



FIG. 10 shows a perspective view of a second embodiment of the present invention in use.



FIG. 11 shows a side view of a second embodiment of the present invention in use.



FIG. 12 shows a front view of a second embodiment of the present invention in use.



FIG. 13 shows a plan view of a third embodiment of the present invention.



FIG. 14 shows a front view of a third embodiment of the present invention with a mask system.



FIG. 15 shows a back view of a third embodiment of the present invention in use.



FIG. 16 shows a side view of a third embodiment of the present invention in use.



FIG. 17 shows a perspective view of a third embodiment of the present invention in use.



FIG. 18 shows a side view of a third embodiment of the present invention in use.



FIG. 19 shows a front view of a third embodiment of the present invention in use.



FIG. 20 shows a front view of a fourth embodiment of the present invention.



FIG. 21 shows a plan view of a fifth embodiment of the present invention.



FIG. 22 shows a side view of a fifth embodiment of the present invention in use.



FIG. 23 shows a front view of a fifth embodiment of present invention in use.





DETAILED DESCRIPTION

A mask system typically includes a frame, a cushion and a headgear. The frame may anchor the cushion in position and allow for attachment of a headgear. The frame is typically a rigid or semi rigid component constructed of, for example, polycarbonate. The cushion may seal with the face of the patient in order to provide therapy to the patient. The cushion is typically a flexible element constructed of, for example, silicone. The headgear may stabilize and support the frame and cushion in position on the patient's face when in use. The headgear is typically a flexible or semi rigid element constructed of, for example, fabric.


Some patients may have difficulty attaining a seal when the mask system is in position on the patients face (both dynamic and static) for several reasons, such as unique facial profiles. Some patients may experience discomfort, such as irritation due to prolonged contact with the mask system, particularly the cushion. In addition, if the patient has damaged skin that may contact the mask system, the patient may need a pad to reduce pressure and enhance healing at the damaged skin when the mask system is next used. A pad may also reduce rubbing of the patient's hair and thereby reduce hair loss.


The present technology relates to a pad for use with a respiratory mask that may be shaped to cover the nasal bridge, forehead region, or any other area of a patient. The pad may be positioned between the patient and the mask system. The pads may have an adhesive to adhere the pad to the face of the patient and/or to the mask, e.g., the seal and/or another part thereof. The pads may have an anchoring or attachment portion, e.g., a ring, to interface with the mask system so as to secure the pad in position on the mask system.


Pad with Adhesive Attachment


In a first embodiment of the present invention, a pad may be provided for use with a mask system that may attach to the patient and/or mask system by an adhesive. Pad preferably includes breathable and/or conformable material, such as foam.


In a first preferred embodiment, the pad may be provided for the nasal bridge region of the patient, as shown in FIGS. 1-5. The pad 100 has a main body portion that may be generally longer than it is wide, so as to accommodate various nose shapes e.g. nose width and nose bridge height. Pad 100 includes lateral side portions that extend across and/or downwards. Lateral side portions terminate along the sides of the nose or on the patient's cheeks.


Pad 100 may be generally elliptical, rectangular, trilobular, or any other desired shape (such as that shown in FIGS. 1 and 2).


Pad 100 may include a peak 120 in its central portion so as to fit a wider range of patients (e.g. to conform over a variety of nasal bridge heights). It may also cover more the of nasal bridge region that tends to suffer the most discomfort or damage (since the top of the nose bridge is a small area, it is most susceptible to skin breakdown as the force from the mask system is distributed over a smaller area, also the skin can be thinner in this region when compared to other regions of the face e.g. cheeks).


Peak 120 may be shaped so as to avoid obstructing the patient's line of sight.


Pad 100 may also have a trough 130 so as to avoid the pad extending past the end of the patient's nose when in use. Furthermore, trough 130 and peak 120 may be shaped such that pad 100 can be easily nested when manufactured, thereby increasing yield, reducing waste and reducing part cost.


Pad 100 may be about 5 mm to 60 mm wide. Preferably, pad 100 is about 10 mm to 50 mm. Preferably, pad 100 may be 45 mm wide. Pad 100 may be the same width along the length of the pad. Pad 100 may not have the same width along the length of the pad. Pad may include lateral side portions to extend down and terminate along the sides of the nose, and may extend along the cheeks, and may seal in the nasal crease.


Pad 100 may be about 10 mm to 200 mm long. Preferably, pad 100 may be about 20 mm to 100 mm. Preferably, pad 100 may be about 100 mm long.


Pad 100 may have adhesive 150 at its distal ends 110 (shown in FIGS. 1 and 2), on one entire side of pad 100 or in any region/s of pad 100.


Pad 100 may be about 1 to 15 mm thick. Preferably, pad 100 is about 5 mm thick. Preferably, pad 100 is about 7 mm thick.


The thickness of pad 100 may be constant along the length of the pad. The thickness of pad 100 may vary along its length, e.g. thicker in the middle where the most force from the mask system is applied; or thinner at the distal ends 110 of the pad where the pad no longer contacts the mask system and may cause leaks. Its thickness may vary from the top of the nose to the nasal bridge region, e.g., thicker near nasal bridge region as compared to nose tip.


Pad 100 may be available in multiple sizes to accommodate varying patient facial profiles, e.g., a number of differently shaped pads 100′, 100″ and 100′″ can be packaged within a lot, as shown in FIGS. 5A, 5B and 5C. Pads may be available in a variety of shapes, see, e.g., FIG. 5D to 5G, to suit noses of various shapes. For example, FIG. 5D suits flatter noses via a smaller angle, whereas FIG. 5G suits sharper noses and has a larger angle, with FIGS. 5E and 5F being suitable for nose shapes in between. Pad 100 may also be customizable so that patients can vary the size of the pad, e.g. perforations to tear off sections of the pad, or markings to indicate where the patient can cut away portions of the pad to suit their facial profile.


Adhesive 150 may contact the patient's face thereby applying the pad directly to the patient's skin (as shown in FIG. 3). The width of the adhesive may be about 10 mm. The mask system 160 may then be positioned on the patient's face and on top of some or all of pad 100 (as shown in FIGS. 4 and 5).


Adhesive 150 may contact the mask system 160 directly and then be applied to the patient's face (no adhesive applied to the face). Also, adhesive may be applied to both sides of the pad, to adhere to the mask system and the patient.


Pad 100 may be constructed from a flexible material. Preferably pad 100 may be constructed from a foam such as that disclosed in pending US patent application US 2008/0047560, filed 27 Jul. 2007; pending US patent application US 2008/0060649, filed 27 Jul. 2007; pending US patent application U.S. Ser. No. 12/448,250, filed 15 Jun. 2009, each incorporated herein by reference in its entirety. Other foams are also possible. Pad 100 may be constructed from fabric (e.g. woven or non-woven), gel, thermoplastic elastomer (TPE) or any other suitable material. Pad 100 may be constructed from a combination of materials e.g. fabric and foam.


Adhesive 150 may be a skin compatible adhesive such as a silicone adhesive. Adhesive may be same as those disclose in pending US patent application U.S. Ser. No. 12/478,537, filed 4 Jun. 2009, included herein by reference in its entirety. The adhesive may be a low tack adhesive.


Adhesive 150 may be covered with a release liner when not in use. Release line may be kraft paper, silicone backed paper or any other suitable material.


Preferably, pad 100 may be formed by die cutting. Pad 100 may be formed by compression cutting. Pad 100 may be formed by molding. Adhesive 150 may be laminated on to the foam before or after cutting the pad.


Pad 100 may be used with a full face mask (i.e. covering the nose and mouth of the patient), or with a nasal-only mask (i.e. cover the nose only), or with nasal pillows (prongs inserted into the patient's nose)


Advantages of the pad are that it may be disposable, intuitive to fit due to the shape and size, comfortable, enable a better or enhanced seal of the mask system when in use, and/or may encourage patient's to be compliant with therapy. The pad is ideally suited to allow both comfort and sealing in areas that are particularly sensitive, while avoiding application of extensive headgear strap tension to compensate for leaks, in which case unwanted pressure can be applied to other areas of the face, such as the cheeks and elsewhere. The pad may provide an improved seal especially with patients that have unusual facial shapes, beards/moustaches, and can assist with stability if the patient uses moisturizer or otherwise has greasy skin. The pad can also help avoid or dissipate uncomfortable leak around the patient's eyes.


Pad with Ring Attachment


In a second embodiment of the present invention, pad 200 may be provided to a mask system 260. Pad 200 may be provided with an attachment portion, e.g., a ring 280 to attach to a portion of mask system 260, such as a forehead support 270.


As shown in FIGS. 6 to 12, pad 200 may be attached to forehead support 270 of mask system 260 by ring 280 of pad 200. Ring 280 may loop over a portion of forehead support 270 (for example, a dial portion or a joining portion 270.1 for a forehead support) such that pad 200 is positioned over the nasal bridge region of mask system 260.


Pad 200 may include a connecting region 225 to join ring 280 to distal ends 210.


Trough 230 may be provided to pad 200 to avoid the pad extending past the end of the patient's nose in use. Trough 230 may have radius of about 20 mm to 40 mm. Preferably, trough 230 may have a radius of about 30 mm.


Pad 200 may be about 100 mm to 130 mm long. Preferably, pad 200 may have a length of about 115 mm.


Pad 200 may be about 75 mm to 130 mm wide. Preferably, pad 200 may have a width of about 100 mm.


Ring 280 may have an inner diameter of about 14 mm to 18 mm. Ring 280 may have an outer diameter of about 40 mm to 44 mm.


In an alternative form shown in FIGS. 21 to 23, pad 500 may connect or otherwise attach to headgear clips 570 or headgear 600. Pad 500 may have a main body 530 that may be shaped to match the sealing profile of mask 360, for example generally triangular, elliptical, trapezoidal. In the case of a nasal-only mask, main body includes a generally horizontal portion to extend above the upper lip. In the case of an oro-nasal mask, the horizontal portion extends below the lower lip (or on the chin). Pad 500 may include one or more attachment portions, e.g., wings or extensions 520 adapted to wrap or extend from the sealing portion of mask 360 to the headgear clips 570 or headgear 600.


Pad 500 may include an aperture 510 to receive a patient's nose and/or mouth for communication with an interior of a mask system. Pad 500, e.g., wings/extensions, may further include rings 580, e.g., in the form of an elongated aperture or slit adapted to connect or receive a headgear clip 570 or headgear 600.


In a third embodiment of the present invention, pad 300 may be provided to a mask system 360. Pad 300 may be provided with an attachment portion, e.g., a ring 380 to attach to a portion of mask system 360, such as a forehead support 370 and provide additional coverage of forehead support pads 375.


As shown in FIGS. 13 to 19, pad 300 may be attached to forehead support 370 of mask system 360 by ring 380 of pad 300. Ring 380 may loop over a portion of forehead support 370 (for example a dial portion) and may additionally fold over the top of forehead support 370, such that pad 300 is positioned over the nasal bridge region of mask system 360.


Distal ends 310 may cover some or a portion of the patient's nasal bridge region and cheeks.


At least one forehead support pad cover 385 may cover some or all of forehead support pad(s) 375 of a forehead support 370.


Pad 300 may include a connecting regions 325 to join ring 380 to forehead pad covers 385 and distal ends 310.


If desired support pad covers 385 may be attached to support pads, without the portion that contacts the nasal bridge region. The pad can have perforations, cutting lines, or pre-scored lines to render various parts removable. For example, the lateral sides of pad covers 385 can be removed along vertical score lines 385.1 to leave only that part of the pad that contacts the patient's nasal bridge region as well as the attachment portion. In another example, a horizontal perforation or score line 385.2 can be used to separate the pad covers 385 and its associated attachment portion from the main body that covers the nasal bridge region. Thus, a single pad can be produced that can be modified by the patient depending on patient preference and/or mask type, e.g., nasal-only mask in which case pad covers 385 would not be needed, or forehead pad cover and attachment portion only, or nasal bridge region with or without attachment portion. See FIG. 13. If only the nasal bridge region is to include padding, the pad is torn along contoured score line 320.1. If the nasal bridge pad is to be used with an attachment portion, then pad covers 385 are removed along score lines 385.1 in which case the upper attachment portion remains. If the upper attachment portion is inappropriately sized, another aperture (lower attachment portion) can be formed by punching out padding along score line 380.1, in which case the upper attachment portion can be separated via score lines 380.2.


Trough 330 may be provided to pad 300 to avoid the pad extending past the end of the patient's nose in use. Trough 330 may have radius of about 20 mm to 40 mm. Preferably, trough 330 may have a radius of about 30 mm.


Pad 300 may be about 155 mm to 205 mm long. Preferably, pad 300 may have a length of about 180 mm.


Pad 300 may be about 75 mm to 130 mm wide. Pad 300 may be about 95 mm to 110 mm wide. Preferably, pad 300 may have a width of about 100 mm.


Pad 300 may be about 1 mm to 15 mm thick. Preferably, pad 300 may have a thickness of about 5 mm. Preferably, pad 300 may have a thickness of about 4 mm.


Forehead support pad covers may be about 25 mm to 40 mm wide.


Ring 380 may have an inner diameter of about 14 mm to 18 mm. Ring 280 may have an outer diameter of about 40 mm to 44 mm. Ring may have a circular opening, or another shape. It may also have a slit to facilitate assembly and disassembly to/from the frame.


Pad 300 may be constructed from a flexible, breathable material. Preferably pad 100 may be constructed from a foam such as that disclosed in pending US patent application US 2008/0047560, filed 27 Jul. 2007; pending US patent application US 2008/0060649, filed 27 Jul. 2007; pending US patent application U.S. Ser. No. 12/448,250, filed 15 Jun. 2009. Other foams are also possible. Pad 300 may be constructed from fabric (e.g. woven or non-woven), gel, thermoplastic elastomer (TPE) or any other suitable material. Pad 300 may be constructed from a combination of materials e.g. fabric and foam.


Pad 300 may be used with a full face mask (i.e. covering the nose and mouth of the patient), or with a nasal-only mask (i.e. cover the nose only).


Advantages of the pad are that it may be disposable, intuitive to fit due to the shape and size, comfortable, enable a better or enhance seal of the mask system when in use, and/or may encourage patient's to be compliant with therapy.


An alternative cushion pad 400 is shown in FIG. 20. Main body portion is similar to that shown in FIGS. 1 and 2. However, extending from peak portion 420 is a forehead support pad cover 485. Connecting portion 425 connects the main body and the pad cover 485. Cushion pad 400 may have a symmetrical shape so it cannot be attached (e.g., adhesively) in the wrong orientation.


Pad 100, 200, 300, 400, 500 (hereafter ‘pad’) may be about 1 mm to 15 mm thick. Preferably, pad may have a thickness of about 5 mm. Preferably, pad may have a thickness of about 4 mm.


Pad may be constructed from a flexible and/or conformable material. Preferably, pad may be constructed from a foam such as that disclosed in pending US patent application US 2008/0047560, filed 27 Jul. 2007; pending US patent application US 2008/0060649, filed 27 Jul. 2007; pending US patent application U.S. Ser. No. 12/448,250, filed 15 Jun. 2009. Other foams are also possible. Pad may be constructed from fabric (e.g. woven or non-woven), gel, thermoplastic elastomer (TPE) or any other suitable material. Pad may be constructed from a combination of materials e.g. fabric and foam.


Pad may be thermoformed and/or die (or compression) cut. Pad may be formed by thermoforming and ultrasonic die cutting. Alternatively, pad may be molded, for example by injection molding, compression molding, etc. In a further alternative, pad may be machined and/or stitched. Pad may be formed by any other suitable means.


Pad may be used with a full face mask (i.e. covering the nose and mouth of the patient), or with a nasal-only mask (i.e. cover the nose only).


Advantages of the pad are that it may be disposable, intuitive to fit due to the shape and size, comfortable, enable a better or enhance seal of the mask system when in use, and/or may encourage patient's to be compliant with therapy. Another advantage of a pad in accordance with the attachment and or tether aspects of the present technology is that it does not fall off the mask and get lost, or become soiled when the mask is removed from the face.


While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. Furthermore, each individual component of any given assembly, one or more portions of an individual component of any given assembly, and various combinations of components from one or more embodiments may include one or more ornamental design features. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, bariatric surgery, etc, derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.

Claims
  • 1. A respiratory mask system configured to deliver a supply of pressurized air to a patient to treat sleep disordered breathing (SDB) with continuous positive airway pressure (CPAP) therapy, the respiratory mask system comprising: a mask;headgear configured to hold the mask in position on the patient during therapy, the headgear including headgear clips and/or headgear straps; anda sealing element constructed of a conformable and breathable material, the sealing element comprising: a main body portion having a central portion shaped to cover a portion of the patient's nose that extends from above the nose tip to the nasal bridge region without obstructing the patient's line of sight, the main body portion having lateral side portions structured to extend downward along the sides of the patient's nose, and the main body portion having an opening configured to receive at least the patient's nose in use; anda pair of attachment portions, each of the attachment portions extending from a corresponding lateral side of the main body portion and each of the attachment portions including an aperture or a slit structured to receive a corresponding one of the headgear clips and/or a corresponding one of the headgear straps,wherein, in use, a first side of the main body portion is configured to contact skin of the patient, and a second side, opposite the first side, is configured to contact the mask, andwherein holes through the sealing element consist of the opening and the aperture or slit positioned on each of the attachment portions.
  • 2. The respiratory mask system according to claim 1, wherein the main body portion includes a horizontal portion connecting the lateral side portions.
  • 3. The respiratory mask system according to claim 2, wherein the horizontal portion is adapted to extend over the upper lip or below the lower lip or on the chin of the patient.
  • 4. The respiratory mask system according to claim 2, wherein each of the attachment portions is formed as an extension or a wing that extends from a corresponding one of the lateral side portions and/or the horizontal portion.
  • 5. The respiratory mask system according to claim 1, wherein the main body portion has a shape that substantially matches a shape of a perimeter of the mask.
  • 6. The respiratory mask system according to claim 1, wherein the sealing element is thermoformed, molded, machined, stitched, die cut and/or compression cut.
  • 7. The respiratory mask system according to claim 1, wherein the conformable and breathable material of the sealing element is foam.
  • 8. The respiratory mask system according to claim 1, wherein the sealing element is configured to be removed from the mask and the headgear for replacement.
  • 9. The respiratory mask system according to claim 1, wherein the mask further comprises: a rigid or semi rigid component constructed of a first material; anda flexible element connected to the rigid or semi rigid component and constructed of a second material that is a different material from the first material.
  • 10. The respiratory mask system according to claim 9, wherein the flexible element is positioned between the rigid or semi rigid component and the sealing element in use.
  • 11. The respiratory mask system according to claim 9, wherein the rigid or semi rigid component and the flexible element at least partly form a breathing cavity configured to receive the supply of pressurized air and provide the supply of pressurized air to the patient's airways.
  • 12. The respiratory mask system according to claim 9, further comprising an elbow configured to be connected to an air delivery conduit to provide a supply of pressurized air from a blower or a flow generator to the rigid or semi rigid component.
  • 13. The respiratory mask system according to claim 9, wherein the conformable and breathable material is a different material from the first material and the second material.
  • 14. The respiratory mask system according to claim 9, wherein the rigid or semi rigid component is a frame, wherein the flexible element is a cushion, andwherein the sealing element is a cushion pad.
  • 15. The respiratory mask system according to claim 1, wherein the conformable and breathable material of the sealing element is fabric.
  • 16. The respiratory mask system according to claim 1, wherein the conformable and breathable material of the sealing element is a combination of fabric and foam.
  • 17. The respiratory mask system according to claim 1, wherein the sealing element includes an upper edge shaped and dimensioned to contact the patient's face below the forehead such that the sealing element avoids contact with the patient's forehead in use.
  • 18. A sealing element for use with a respiratory mask system configured to deliver continuous positive airway pressure (CPAP) therapy to a patient to treat sleep disordered breathing (SDB) and including a mask, the sealing element comprising: a main body portion having a generally triangular shape, the main body portion further comprising: a central portion shaped to cover a portion of the patient's nose without obstructing the patient's line of sight;a pair of lateral side portions, each of the lateral side portions structured to extend from the central portion and along corresponding lateral sides of the patient's nose; anda horizontal portion connecting the pair of lateral side portions of the main body portion; anda pair of attachment portions, each of the attachment portions extending from a corresponding lateral side of the main body portion and each of the attachment portions including an aperture that is structured to receive a portion of a component configured to hold the respiratory mask system in position on the patient during use,wherein the sealing element is constructed from a breathable material,wherein the central portion, the lateral side portions, and the horizontal portion of the main body portion form an opening that is configured to receive the patient's nose and mouth;wherein, in use, a first side of the main body portion is configured to contact skin of the patient, and a second side, opposite the first side, is configured to contact the mask, andwherein holes through the sealing element consist of the opening and the aperture positioned on each of the attachment portions.
  • 19. The sealing element according to claim 18, wherein the horizontal portion is adapted to extend below the lower lip of the patient.
  • 20. The sealing element according to claim 18, wherein the component is a corresponding headgear clip or a corresponding headgear strap of headgear.
  • 21. The sealing element according to claim 18, wherein each of the attachment portions is formed as an extension or a wing that extends from a corresponding one of the lateral side portions and/or the horizontal portion.
  • 22. The sealing element according to claim 18, wherein the main body portion has a shape that substantially matches a shape of a perimeter of the mask.
  • 23. The sealing element according to claim 18, wherein the sealing element is thermoformed, molded, machined, stitched, die cut and/or compression cut.
  • 24. The sealing element according to claim 18, wherein the sealing element is constructed from foam.
  • 25. The sealing element according to claim 18, wherein the sealing element is constructed from fabric.
  • 26. The sealing element according to claim 18, wherein the sealing element is constructed from a combination of fabric and foam.
  • 27. The sealing element according to claim 18, wherein the sealing element includes an upper edge shaped and dimensioned to contact the patient's face below the forehead such that the sealing element avoids contact with the patient's forehead in use.
  • 28. A respiratory mask system configured to deliver CPAP therapy to a patient to treat SDB, the respiratory mask system comprising: a mask comprising: a rigid or semi rigid component constructed of a first material; anda flexible element connected to the rigid or semi rigid component and constructed of a second material that is a different material from the first material;an elbow configured to be connected to an air delivery conduit to provide a supply of pressurized air from a blower or a flow generator to the rigid or semi rigid component;headgear configured to hold the rigid or semi rigid component and the flexible element in position on the patient during therapy, the headgear including headgear clips and/or headgear straps; andthe sealing element according to claim 18.
  • 29. The respiratory mask system according to claim 28, wherein the flexible element is positioned between the rigid or semi rigid component and the sealing element in use.
  • 30. The respiratory mask system according to claim 28, wherein the rigid or semi rigid component and the flexible element at least partly form a breathing cavity configured to receive the supply of pressurized air and provide the supply of pressurized air to the patient's airways.
  • 31. The respiratory mask system according to claim 28, wherein the sealing element is configured to be removed from the mask and the headgear for replacement.
Priority Claims (1)
Number Date Country Kind
2009903495 Jul 2009 AU national
CROSS REFERENCE TO PRIORITY APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/801,377, now U.S. Pat. No. 9,901,699, which claims the benefit of Australian Application No. AU 2009903495, filed Jul. 24, 2009, and is a continuation-in-part of U.S. application Ser. No. 12/478,537, filed Jun. 4, 2009, now U.S. Pat. No. 8,291,906, which claims the benefit of U.S. Provisional Application No. 61/058,659, filed Jun. 4, 2008 and No. 61/080,847, filed Jul. 15, 2008, each incorporated herein by reference in its entirety.

US Referenced Citations (107)
Number Name Date Kind
3357426 Cohen Dec 1967 A
3594813 Sanderson Jul 1971 A
3682171 Dali et al. Aug 1972 A
3972321 Proctor Aug 1976 A
4006744 Steer Feb 1977 A
4142527 Garcia Mar 1979 A
4153051 Shippert May 1979 A
4274402 Shippert Jun 1981 A
4454881 Huber Jun 1984 A
4548200 Wapner Oct 1985 A
4711636 Bierman Dec 1987 A
4767411 Edmunds Aug 1988 A
4790829 Bowden et al. Dec 1988 A
4802857 Laughlin Feb 1989 A
4838878 Kalt et al. Jun 1989 A
4919654 Kalt Apr 1990 A
4966590 Kalt Oct 1990 A
4969880 Zamierowski Nov 1990 A
4976698 Stokley Dec 1990 A
5117818 Palfy Jun 1992 A
5243971 Sullivan et al. Sep 1993 A
5261893 Zamierowski Nov 1993 A
5263939 Wortrich Nov 1993 A
5304146 Johnson et al. Apr 1994 A
5364367 Banks et al. Nov 1994 A
5438710 McDonald et al. Aug 1995 A
5513635 Bedi May 1996 A
5537687 Garza Jul 1996 A
5682881 Winthrop et al. Nov 1997 A
5707342 Tanaka Jan 1998 A
5735272 Dillon et al. Apr 1998 A
5752511 Simmons et al. May 1998 A
5807341 Heim Sep 1998 A
5842469 Rapp et al. Dec 1998 A
5918598 Belfer et al. Jul 1999 A
6026811 Settle Feb 2000 A
6095996 Steer et al. Aug 2000 A
6119694 Correa et al. Sep 2000 A
6211263 Cinelli et al. Apr 2001 B1
6231548 Bassett May 2001 B1
6258066 Urich Jul 2001 B1
6328038 Kessler et al. Dec 2001 B1
6338340 Finch et al. Jan 2002 B1
6341606 Bordewick et al. Jan 2002 B1
6358279 Tahi et al. Mar 2002 B1
6419660 Russo Jul 2002 B1
6419687 Berke Jul 2002 B1
6423036 Van Huizen Jul 2002 B1
6434796 Speirs Aug 2002 B1
6448303 Paul Sep 2002 B1
6482178 Andrews et al. Nov 2002 B1
6532961 Kwok Mar 2003 B1
6533410 Shefler et al. Mar 2003 B1
6561192 Palmer May 2003 B2
6579267 Lynch et al. Jun 2003 B2
6607516 Cinelli et al. Aug 2003 B2
6663600 Bierman et al. Dec 2003 B2
6669712 Cardoso Dec 2003 B1
6710099 Cinelli et al. Mar 2004 B2
6886564 Sullivan et al. May 2005 B2
6972003 Bierman et al. Dec 2005 B2
7018362 Bierman et al. Mar 2006 B2
7076282 Munro et al. Jul 2006 B2
7146976 McKown Dec 2006 B2
7152601 Barakat et al. Dec 2006 B2
7207328 Altemus Apr 2007 B1
D552733 Criscuolo et al. Oct 2007 S
7472703 Hernandez Jan 2009 B2
8113202 Ho Feb 2012 B2
8365733 Rutan Feb 2013 B2
8800563 Doherty et al. Aug 2014 B2
20020066452 Kessler et al. Jun 2002 A1
20020143296 Russo Oct 2002 A1
20020157673 Kessler et al. Oct 2002 A1
20020185134 Bishop Dec 2002 A1
20030023182 Mault et al. Jan 2003 A1
20030145857 Sullivan Aug 2003 A1
20040106891 Langan et al. Jun 2004 A1
20040111104 Schein et al. Jun 2004 A1
20040127856 Johnson Jul 2004 A1
20040211427 Jones, Jr. Oct 2004 A1
20040216746 Jones, Jr. et al. Nov 2004 A1
20040226564 Persson Nov 2004 A1
20050051171 Booth Mar 2005 A1
20050101933 Marrs et al. May 2005 A1
20060095008 Lampropoulos et al. May 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20070163594 Ho et al. Jul 2007 A1
20070282272 Bannon et al. Dec 2007 A1
20080004573 Kaufmann et al. Jan 2008 A1
20080060649 Veliss Mar 2008 A1
20080065022 Kyvik et al. Mar 2008 A1
20080110469 Weinberg May 2008 A1
20080200880 Kyvik et al. Aug 2008 A1
20080302365 Cohen Dec 2008 A1
20090044908 Behrens et al. Feb 2009 A1
20090107507 Moore Apr 2009 A1
20090139525 Schirm Jun 2009 A1
20090223522 Hernandez Sep 2009 A1
20090229610 Oates et al. Sep 2009 A1
20090293880 Rutan Dec 2009 A1
20100000534 Kooij et al. Jan 2010 A1
20100018535 Chimenti et al. Jan 2010 A1
20100031958 Stewart Feb 2010 A1
20100229868 Rummery et al. Sep 2010 A1
20110005524 Veliss et al. Jan 2011 A1
20110209701 Derringer et al. Sep 2011 A1
Foreign Referenced Citations (11)
Number Date Country
197 03 526 Aug 1998 DE
0 466 960 Jan 1992 EP
0 776 679 Jun 1997 EP
WO 9823305 Jun 1998 WO
WO 9916327 Apr 1999 WO
WO 9925410 May 1999 WO
WO 0050121 Aug 2000 WO
WO 0238221 May 2002 WO
WO 2007143772 Dec 2007 WO
WO 2009146313 Dec 2009 WO
WO 2010011575 Jan 2010 WO
Non-Patent Literature Citations (15)
Entry
The Pad-A-Cheek website screen grab, http://www.padacheek.com/PAC_Maskliners.html, available as of May 31, 2010 (Year: 2010).
Ultra Mirage Full Face Mask User Guide (Year: 2005).
Pad-A-Cheek website, http://www.padacheek.com/PAC_Maskliners.html, available as of May 31, 2010.
ResMed, Ultra Mirage Full Face Mask User Guide, copyright 2005.
Adam J. Singer MD et al., “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, vol. 26, 2008, pp. 490-496.
Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136.
GaleMed Corporation Components Supply Brochure, 30 pages, 2005.
Chimenti et al., U.S. Appl. No. 61/083,480, filed Jul. 24, 2008.
Kooij, et al., U.S. Appl. No. 61/080,847, filed Jul. 15, 2008.
Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224.
Extended European Search Report dated Sep. 3, 2009 in corresponding EP Application No. 09161984.1.
GaleMed Pad Photo 1, 1 page.
Chinese Office Action for Application No. 201010198269.7 w/ English translation dated Jan. 27, 2014, 16 pages.
Notification of the Third Office Action issued in Application No. 201010198269.7 w/ English translation dated Apr. 22, 2015, 10 pages.
Chinese Office Action for Application No. 201010198269.7 w/ English translation dated Oct. 8, 2014, 14 pages.
Related Publications (1)
Number Date Country
20180140794 A1 May 2018 US
Provisional Applications (2)
Number Date Country
61058659 Jun 2008 US
61080847 Jul 2008 US
Continuations (1)
Number Date Country
Parent 12801377 Jun 2010 US
Child 15872427 US
Continuation in Parts (1)
Number Date Country
Parent 12478537 Jun 2009 US
Child 12801377 US